The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.
NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has signed a supply and distribution agreement enabling it to offer its customers access to Sirion Biotech's RNAiONE custom short hairpin RNA development services.
A study published in Nature Genetics last month has identified a genetic variant strongly associated with higher risk of certain brain tumors, and suggests the involvement of a long non-coding RNA or a microRNA.
Alnylam Pharmaceuticals this week announced that it has taken a non-exclusive license to RNAi-related intellectual property held by UK technology management firm Plant Bioscience Limited.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
